https://www.selleckchem.com/products/ca3.html
01 to1.05), required less contrast volume (MD=-18.64 95% CI -30.89 to -6.39) and fluoroscopy time (MD=-9.12; 95% CI -16.90 to -1.34) compared with males. There was no statistical difference in in-hospital (RR=1.50; 95% CI 0.73 to 3.09) or longer term (≥6 months) all-cause mortality (RR=1.10; 95% CI 0.86 to 1.42) between the two groups. CTO PCI is feasible and safe in female patients with comparable outcomes in female versus male patients. CTO PCI is feasible and safe in female patients with comparable outcomes in female versus male patients
Like
Comment
Share
